Patients with lung cancer reduce smoking rate after enrollment in phase III clinical trial

(International Association for the Study of Lung Cancer) The first comprehensive, prospective study of smoking habits in patients with non-small cell lung cancer (NSCLC) who were enrolled in a phase III early-stage trial revealed that there was a high rate of smoking reduction and cessation following study entry, according to research published today in theJournal of Thoracic Oncology.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news